| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide an antisense oligonucleotide derivative which inhibits the expression of human IL-6 and a novel therapeutic agent for renal carcinoma. <P>SOLUTION: The therapeutic agent for renal carcinoma has an antisense oligonucleotide derivative corresponding to, for example, a continuous base sequence of at least 9 bases including the translation initiation codon of mRNA coding for human interleukin-6 receptor (human IL-6R) as an active ingredient. <P>COPYRIGHT: (C)2006,JPO&NCIPI |
